Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Related structures:
AlphaFold database: E9B169
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 10 | 14 | PF00656 | 0.642 |
CLV_NRD_NRD_1 | 68 | 70 | PF00675 | 0.557 |
CLV_PCSK_SKI1_1 | 188 | 192 | PF00082 | 0.541 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.564 |
DEG_SCF_FBW7_2 | 150 | 157 | PF00400 | 0.651 |
DOC_MAPK_MEF2A_6 | 15 | 24 | PF00069 | 0.625 |
DOC_PP1_RVXF_1 | 125 | 131 | PF00149 | 0.424 |
DOC_PP1_RVXF_1 | 34 | 41 | PF00149 | 0.527 |
DOC_PP2B_PxIxI_1 | 108 | 114 | PF00149 | 0.419 |
DOC_PP4_FxxP_1 | 40 | 43 | PF00568 | 0.529 |
DOC_USP7_MATH_2 | 25 | 31 | PF00917 | 0.510 |
DOC_USP7_UBL2_3 | 199 | 203 | PF12436 | 0.618 |
DOC_WW_Pin1_4 | 150 | 155 | PF00397 | 0.516 |
DOC_WW_Pin1_4 | 171 | 176 | PF00397 | 0.638 |
DOC_WW_Pin1_4 | 68 | 73 | PF00397 | 0.562 |
LIG_BRCT_BRCA1_1 | 172 | 176 | PF00533 | 0.505 |
LIG_FHA_1 | 2 | 8 | PF00498 | 0.592 |
LIG_FHA_1 | 69 | 75 | PF00498 | 0.565 |
LIG_FHA_2 | 133 | 139 | PF00498 | 0.448 |
LIG_FHA_2 | 150 | 156 | PF00498 | 0.515 |
LIG_FHA_2 | 50 | 56 | PF00498 | 0.632 |
LIG_FHA_2 | 8 | 14 | PF00498 | 0.661 |
LIG_LIR_Nem_3 | 4 | 8 | PF02991 | 0.557 |
LIG_Pex14_2 | 5 | 9 | PF04695 | 0.619 |
LIG_SH2_CRK | 18 | 22 | PF00017 | 0.532 |
LIG_SH2_CRK | 187 | 191 | PF00017 | 0.548 |
LIG_SH2_STAP1 | 28 | 32 | PF00017 | 0.473 |
LIG_SH2_STAT5 | 48 | 51 | PF00017 | 0.640 |
LIG_SH2_STAT5 | 76 | 79 | PF00017 | 0.630 |
LIG_SH3_3 | 187 | 193 | PF00018 | 0.539 |
LIG_SH3_3 | 19 | 25 | PF00018 | 0.525 |
LIG_SH3_3 | 40 | 46 | PF00018 | 0.534 |
LIG_SH3_3 | 84 | 90 | PF00018 | 0.459 |
LIG_WRC_WIRS_1 | 8 | 13 | PF05994 | 0.538 |
LIG_WW_1 | 20 | 23 | PF00397 | 0.515 |
MOD_CK1_1 | 30 | 36 | PF00069 | 0.528 |
MOD_CK2_1 | 131 | 137 | PF00069 | 0.468 |
MOD_CK2_1 | 149 | 155 | PF00069 | 0.407 |
MOD_CK2_1 | 214 | 220 | PF00069 | 0.583 |
MOD_Cter_Amidation | 67 | 70 | PF01082 | 0.555 |
MOD_GlcNHglycan | 216 | 219 | PF01048 | 0.601 |
MOD_GSK3_1 | 149 | 156 | PF00069 | 0.560 |
MOD_N-GLC_1 | 131 | 136 | PF02516 | 0.414 |
MOD_N-GLC_1 | 74 | 79 | PF02516 | 0.673 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.553 |
MOD_NEK2_1 | 38 | 43 | PF00069 | 0.558 |
MOD_NEK2_1 | 7 | 12 | PF00069 | 0.551 |
MOD_NEK2_1 | 74 | 79 | PF00069 | 0.658 |
MOD_PKA_1 | 214 | 220 | PF00069 | 0.583 |
MOD_PKA_2 | 30 | 36 | PF00069 | 0.518 |
MOD_Plk_1 | 55 | 61 | PF00069 | 0.594 |
MOD_ProDKin_1 | 150 | 156 | PF00069 | 0.515 |
MOD_ProDKin_1 | 171 | 177 | PF00069 | 0.640 |
MOD_ProDKin_1 | 68 | 74 | PF00069 | 0.556 |
MOD_SUMO_rev_2 | 141 | 151 | PF00179 | 0.495 |
MOD_SUMO_rev_2 | 173 | 182 | PF00179 | 0.677 |
TRG_DiLeu_BaLyEn_6 | 3 | 8 | PF01217 | 0.624 |
TRG_ENDOCYTIC_2 | 187 | 190 | PF00928 | 0.592 |
TRG_ENDOCYTIC_2 | 23 | 26 | PF00928 | 0.499 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P4Q1 | Leptomonas seymouri | 80% | 99% |
A0A0S4ITD8 | Bodo saltans | 66% | 96% |
A0A1X0P1R4 | Trypanosomatidae | 78% | 99% |
A0A3S7X3U1 | Leishmania donovani | 98% | 100% |
A4HIM9 | Leishmania braziliensis | 92% | 100% |
A4I5X5 | Leishmania infantum | 98% | 100% |
C9ZR99 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 79% | 95% |
Q4Q6Z6 | Leishmania major | 96% | 100% |
V5BSK1 | Trypanosoma cruzi | 76% | 100% |